Yong-mei Yin

Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.

Xuan Pan, Zhaoxia Wang, Bin-bin Lu, 2012, The international journal of biochemistry & cell biology.

Restoration of Gefitinib Efficacy Following Chemotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer

Hua Shen, Jing Sun, Y. Shu, 2010, Oncology Research and Treatment.

Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China

Ming Yan, Y. Qiao, Jin-Hu Fan, 2022, Annals of translational medicine.

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial.

J. Ragaz, Jiong Wu, Bing-he Xu, 2015, The Lancet. Oncology.

The pathological and clinical landscape of refractory metastatic triple negative breast cancer: a narrative review

Jingfeng Tang, Xiang Huang, Yong-mei Yin, 2022, Annals of translational medicine.